Amanote Research
Register
Sign In
Febuxostat: The Evidence for Its Use in the Treatment of Hyperuricemia and Gout
Core Evidence
- New Zealand
doi 10.2147/ce.s5999
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Reviews
References
Pharmacology
Date
June 1, 2009
Authors
Unknown
Publisher
Informa UK Limited
Related search
The Urate-Lowering Efficacy and Safety of Febuxostat in the Treatment of the Hyperuricemia of Gout: The CONFIRMS Trial
Arthritis Research and Therapy
Rheumatology
Allergy
Immunology
Febuxostat Treatment for Gout: What the Clinician Needs to Know
Therapeutic Advances in Musculoskeletal Disease
Rheumatology
Orthopedics
Sports Medicine
Intermittent Control of Hyperuricemia in the Treatment of Gout: 186
Pediatric Research
Child Health
Pediatrics
Perinatology
Autoinflammation in the Pathogenesis of Gout and Hyperuricemia
Clinical pharmacology and therapy
Febuxostat for the Treatment of Chronic Tophaceous Gout in a Patient on Continuous Ambulatory Peritoneal Dialysis
The Korean Journal of Medicine
Urate Transporters: Transforming the Face of Hyperuricemia and Gout
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Switching From Allopurinol to Febuxostat for the Treatment of Hyperuricemia and Renal Function in Patients With Chronic Kidney Disease
Clinical Rheumatology
Medicine
Rheumatology
Febuxostat Is a Novel Drug in Therapy for Gout
Nauchno-Prakticheskaya Revmatologiya
Rheumatology
Allergy
Immunology
Febuxostat in the Therapy of Gout: From Theory to Practice
Modern Rheumatology Journal